SN · Pharma and healthcare · one day
Smith & Nephew (SN): news on Saturday 7 November 2026
News from the 24 hours to Saturday morning, 7 November 2026.
Tone of the day
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
Coverage was mainly an analyst downgrade citing sluggish growth and a shifting outlook, which pulls sentiment negative. A separate item noted neutral analyst views, adding little offsetting support.
What drove it
- analyst downgrade
- slow growth
- neutral analyst views
Around this day
2 stories · 2 headlines · strongest first
Pharma and healthcare on 7 NovemberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| Seeking Alpha downgrades Smith & Nephew −7.51 headline today · An analyst piece downgrades Smith & Nephew citing sluggish growth and a shifting outlook. | ||
| −7.5 | Analyst downgrade citing slow growth and weaker outlook for the company. | |
| Analysts neutral on Smith & Nephew −0.81 headline today · A list piece includes Smith & Nephew among stocks with neutral analyst views. | ||
| −0.8 | Analyst stance described as neutral, grouped with one other stock. | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated Smith & Nephew: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.